Cellebrite DI Ltd. CLBT
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $475.68M, +18.6% YoY · Filed Mar 3, 2026
Cellebrite DI Ltd. (CLBT) files with the SEC under industry code 7372, Services-Prepackaged Software. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $475.7 million and net income of $78.3 million. Free cash flow was $160.3 million. As of Dec 31, 2025 it held $374.0 million in cash and investments and $22.7 million in total debt.
Revenue
$475.68M
+18.6% vs prior year
Net income
$78.33M
+127.7% vs prior year
Operating cash flow
$173.54M
+31.3% vs prior year
Free cash flow
$160.32M
+29.7% vs prior year
EPS
$0.31
+123.0% vs prior year
Dividend per share
None
Shares outstanding
249.44M
+4.2% vs prior year
Net cash
$351.29M
FY 2025
Operating margin
14.0%
FY 2025
Company profile
- Industry
- Services-Prepackaged Software (SIC 7372)
- Listed as
- CLBT (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Petah Tikva, Israel
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1854587
Other Services-Prepackaged Software companies
- Microsoft Corp MSFT
- Palantir Technologies Inc. PLTR
- Oracle Corp ORCL
- Sap SE SAP
- CrowdStrike Holdings, Inc. CRWD
- Shopify Inc. SHOP
- Salesforce, Inc. CRM
- ServiceNow, Inc. NOW
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2022 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $475.7M | $401.2M | $325.1M | $270.7M | $246.2M |
| Operating income | $66.5M | $56.9M | $33.2M | $1.0M | $13.8M |
| Net income | $78.3M | -$283.0M | -$81.1M | $120.8M | $71.4M |
| Diluted EPS | $0.31 | -$1.35 | -$0.43 | $0.59 | $0.44 |
| Operating cash flow | $173.5M | $132.2M | $102.1M | $20.6M | $36.1M |
| Free cash flow | $160.3M | $123.6M | $96.8M | $13.7M | $30.9M |
| Total assets | $938.9M | $690.6M | $532.9M | $403.3M | $339.8M |
| Total liabilities | $454.5M | $354.5M | $498.7M | $329.4M | $413.1M |
| Stockholders' equity | $484.3M | $336.0M | $34.2M | $73.9M | -$73.3M |
| Cash and investments | $374.0M | $330.1M | $257.1M | $154.4M | $146.0M |
| Total debt | $22.7M | $11.0M | $14.1M | $15.4M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 24, 2026 |
| 6-K | Current report (foreign issuer) | Sep 2, 2026 | Sep 2, 2026 |
| 6-K | Current report (foreign issuer) | Aug 18, 2026 | Aug 18, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
All 358 Cellebrite DI Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.